PPIF Antibody - #DF3147

(5)   (10)  
製品: PPIF Antibody
カタログ: DF3147
タンパク質の説明: Rabbit polyclonal antibody to PPIF
アプリケーション: WB IHC IF/ICC
反応性: Human, Mouse, Rat
予測: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken
分子量: 22 KD; 22kD(Calculated).
ユニプロット: P30405
RRID: AB_2835524

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先
関連ダウンロード
MS Report
HPLC Report
MSDS
説明書
COA
プロトコル
WB Handbook
IHC Protocol
IF/ICC Protocol

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:1000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Pig(91%), Bovine(91%), Horse(100%), Sheep(91%), Rabbit(100%), Dog(100%), Chicken(91%)
クローナリティ:
Polyclonal
特異性:
PPIF Antibody detects endogenous levels of total PPIF.
RRID:
AB_2835524
引用形式: Affinity Biosciences Cat# DF3147, RRID:AB_2835524.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ／展開

Cyclophilin 3; cyclophilin D; Cyclophilin F; Cyp D; CyP M; CYP3; CypD; hCyP3; mitochondrial; Mitochondrial cyclophilin; Peptidyl prolyl cis trans isomerase, mitochondral; Peptidyl-prolyl cis-trans isomerase F; Peptidyl-prolyl cis-trans isomerase F, mitochondrial; Peptidylprolyl isomerase F (cyclophilin F); Peptidylprolyl isomerase F; PPIase; PPIase F; Ppif; PPIF_HUMAN; Rotamase; Rotamase F;

免疫原

免疫原:
Uniprot:

P30405(PPIF_HUMAN) >>Visit HPA database.

遺伝子(ID):
PPIF(10105)
タンパク質配列:
MLALRCGSRWLGLLSVPRSVPLRLPAARACSKGSGDPSSSSSSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVKEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Horse
100
Dog
100
Rabbit
100
Pig
91
Bovine
91
Sheep
91
Chicken
91
Xenopus
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - P30405 基板として

Site PTM Type Enzyme
S31 Phosphorylation P31751 (AKT2)
S34 Phosphorylation
K57 Acetylation
K67 Acetylation
K73 Acetylation
K73 Sumoylation
K73 Ubiquitination
K86 Acetylation
K86 Ubiquitination
Y90 Phosphorylation
K91 Acetylation
S123 Phosphorylation
K167 Acetylation
K175 Acetylation
K182 Acetylation
K183 Acetylation
S186 Phosphorylation
S189 Phosphorylation
K190 Methylation
K190 Ubiquitination
S191 Phosphorylation
C203 S-Nitrosylation

研究背景

機能:

PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding. Involved in regulation of the mitochondrial permeability transition pore (mPTP). It is proposed that its association with the mPTP is masking a binding site for inhibiting inorganic phosphate (Pi) and promotes the open probability of the mPTP leading to apoptosis or necrosis; the requirement of the PPIase activity for this function is debated. In cooperation with mitochondrial TP53 is involved in activating oxidative stress-induced necrosis. Involved in modulation of mitochondrial membrane F(1)F(0) ATP synthase activity and regulation of mitochondrial matrix adenine nucleotide levels. Has anti-apoptotic activity independently of mPTP and in cooperation with BCL2 inhibits cytochrome c-dependent apoptosis.

PTMs:

Deacetylated at Lys-167 by SIRT3.

細胞の位置付け:

Mitochondrion matrix.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
サブユニット構造:

Associates with the mitochondrial membrane ATP synthase F(1)F(0) ATP synthase; the association is increased by inorganic phosphate (Pi) and decreased by cyclosporin A (CsA). Interacts with ATP5F1B; ATP5PD and ATP5PO. Interacts with SLC25A3; the interaction is impaired by CsA. Interacts with BCL2; the interaction is impaired by CsA. Interacts with TP53; the association implicates preferentially tetrameric TP53, is induced by oxidative stress and is impaired by CsA. Interacts with C1QBP. Interacts with MCUR1. Component of the mitochondrial permeability transition pore complex (mPTPC), at least composed of SPG7, VDAC1 and PPIF. Interacts with SPG7.

タンパク質ファミリー:

Belongs to the cyclophilin-type PPIase family.

研究領域

· Environmental Information Processing > Signal transduction > Calcium signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > cGMP-PKG signaling pathway.   (View pathway)

· Human Diseases > Neurodegenerative diseases > Parkinson's disease.

· Human Diseases > Neurodegenerative diseases > Huntington's disease.

· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.

参考文献

1). Emodin targets mitochondrial cyclophilin D to induce apoptosis in HepG2 cells. BIOMEDICINE & PHARMACOTHERAPY (PubMed: 28363167) [IF=7.5]

Application: WB    Species: human    Sample:

Fig. 3. Effects of ROS and ERK on CypD expression. Cells were treated with emodin in the absence or presence of 5mM CsA or 10 ng/mL EGF for 48 h, or 5 mM NAC for 6 h. Protein expression was determined by western blots. (A) CypD expression in the absence or presence of CsA. (B) p-ERK expression induced by emodin. (C) CypD expression in the absence or presence of EGF. (D) CypD expression in the absence or presence of NAC. (E) Determination of emodin-induced cytotoxicity activity in the absence or presence of EGF or NAC by MTT assay. Values are expressed as the means  SD; n = 3, * p < 0.05 versus control.
2). Chrysophanol localizes in mitochondria to promote cell death through upregulation of mitochondrial cyclophilin D in HepG2 cells. Chinese Herbal Medicines (PubMed: 36117497) [IF=3.8]
3). Therapeutic effect and mechanism of 4‑phenyl butyric acid on renal ischemia‑reperfusion injury in mice. Experimental and Therapeutic Medicine (PubMed: 35069825) [IF=2.7]

Application: WB    Species: human    Sample: HK‑2 cells

Figure 2. | Expression levels of CypD, cytochrome c, eIF2α and GRP78 in HK‑2 cells following hypoxia/reoxygenation and DEX and 4‑PBA treatment. The left panel presents representative western blotting, and the right panel shows the quantified relative protein levels. *P<0.05 vs. control; #P<0.05 vs. model. CypD,cyclophilin D; eIF2α, eukaryotic translation initiation factor 2α; GRP78, glucose‑regulated protein 78.

Application: WB    Species: Human    Sample: HK-2 cells

Figure 2 Expression levels of CypD, cytochrome c, eIF2α and GRP78 in HK-2 cells following hypoxia/reoxygenation and DEX and 4-PBA treatment. The left panel presents representative western blotting, and the right panel shows the quantified relative protein levels. *P<0.05 vs. control; #P<0.05 vs. model. CypD, cyclophilin D; eIF2α, eukaryotic translation initiation factor 2α; GRP78, glucose-regulated protein 78.
4). Cyclophilin D Regulates Oxidative Stress and Apoptosis via Mitochondrial Permeability Transition Pore in Acute Acalculous Cholecystitis. CURRENT MOLECULAR MEDICINE (PubMed: 36089783) [IF=2.5]
5). Bishonokiol A Induces Multiple Cell Death in Human Breast Cancer MCF-7 Cells. Asian Pacific Journal of Cancer Prevention (PubMed: 32334473)

Application: WB    Species: Human    Sample: Breast Cancer MCF-7 Cells

Figure 3 BHNKA Induced Necroptosis in Human Breast Cancer MCF-7 Cells. (A), Morphological characteristics of cells treated with BHNKA (40 μM) for 24h by electron microscope. Red arrowheads indicated cell membrane integrity and swelling of cellular orgenelles. (B), Cell viability following treated with BHNKA (40 μM) with or without pre-treatment with necroptosis inhibitors (20 μM of Nec-1 and CsA) were measured by MTT assay. (C), Western blotting analyses were used to measure the expression of necroptosis-related proteins, such as RIP1, RIP3, MLKL, and CypD. * P < 0.05 compared with the control

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.